Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BREACH-TB
NCT06568484Phase 3Recruiting
- Sponsor
- Johns Hopkins University
- Start
- May 2026
- Primary completion
- Jul 2027
- Countries
- 4
01
Overview
A Phase 3 trial of bedaquiline in Tuberculosis (TB), sponsored by Johns Hopkins University. Started May 2026; status: recruiting.
02
Drugs
bedaquiline
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT06568484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06568484.